Hydrochloric Acid

Hydrochloric Acid

SCHEMBL1914719

CCCC(CC)[N+](C)(C)O.[Cl-]

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CHRM1 known ✓ P11229 1/20 0.31
CHRM3 known ✓ P20309 1/20 0.31
SLC6A3 known ✓ Q01959 1/20 0.31
TSHR P16473 1/20 0.38
LMNA P02545 1/20 0.32
AKR1A1 P14550 1/20 0.31
HTR2A P28223 1/20 0.31
HTR2C P28335 1/20 0.31
ADRA1A P35348 1/20 0.31
HRH1 P35367 1/20 0.31
DRD3 P35462 1/20 0.31
HDAC1 Q13547 1/20 0.31
HDAC2 Q92769 1/20 0.31
TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9719666 0.84 PSMD14 (0.42) LMNA
Hydrochloric Acid SCHEMBL4889265 0.84 PSMD14 (0.42) LMNA
Hydrochloric Acid SCHEMBL4895294 0.84 PSMD14 (0.42) LMNA
Hydrochloric Acid SCHEMBL4894359 0.84 PSMD14 (0.42) LMNA
Hydrochloric Acid SCHEMBL4891156 0.84 PSMD14 (0.42) LMNA
SCHEMBL8139870 0.80 LMNA (0.43) LMNA
SCHEMBL8152563 0.80 LMNA (0.43) LMNA
Hydrochloric Acid SCHEMBL19436589 0.79 PSMD14 (0.42) LMNA
SCHEMBL27285776 0.73 TSHR (0.36) TSHRLMNA
Hydrochloric Acid SCHEMBL28346423 0.72 SLC22A1 (0.40) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3368592-B1 COSMETIC COMPOSITION, COSMETIC, AND EXTERNAL PREPARATION FOR SKIN DOW TORAY CO LTD (JP) 2025-12-03 EP disclosed
US-11820846-B2 Composition, method of preparing copolymer, and methods and end uses thereof DOW SILICONES CORPORATION (US) 2023-11-21 US disclosed
EP-2492301-B1 NOVEL CO-MODIFIED ORGANOPOLYSILOXANE DOW TORAY CO LTD (JP) 2023-03-29 EP disclosed
US-20220112322-A1 COMPOSITION, METHOD OF PREPARING COPOLYMER, AND METHODS AND END USES THEREOF DOW TORAY CO., LTD. (JP) 2022-04-14 US disclosed
EP-2658899-A1 COSMETIC CONTAINING LIQUID ORGANOPOLYSILOXANE Dow Corning Toray Co., Ltd. (JP) 2013-11-06 EP disclosed
EP-2515841-A1 COPOLYMER HAVING CARBOSILOXANE DENDRIMER STRUCTURE, AND COMPOSITION AND COSMETIC CONTAINING THE SAME Dow Corning Toray Co., Ltd. (JP) 2012-10-31 EP disclosed
WO-2012091155-A1 COSMETIC CONTAINING LIQUID ORGANOPOLYSILOXANE DOW CORNING TORAY CO., LTD. (JP) 2012-07-05 WO disclosed
WO-2011078407-A1 COPOLYMER HAVING CARBOSILOXANE DENDRIMER STRUCTURE, AND COMPOSITION AND COSMETIC CONTAINING THE SAME DOW CORNING TORAY CO., LTD. (JP) 2011-06-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11820846-B2 Composition, method of preparing copolymer, and methods and end uses thereof BRS3, OXSR1, OXER1 CHRM1 79/4885CHRM3 32/4885SLC6A3 3587/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.